ARPA-H Rare Disease AI/ML and Precision Integrated Diagnostics (RAPID) Patients’ Day
ID: ARPA-H-SN-25-127Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)

Original Source

https://sam.gov/opp/229d3cd40bbe46d9892c4e2ea4090d79/view
Timeline
  1. 1
    Posted Jan 13, 2025, 12:00 AM UTC
  2. 2
    Updated Feb 21, 2025, 12:00 AM UTC
  3. 3
    Due Feb 21, 2025, 5:00 PM UTC
Description

The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a virtual Patients’ Day on February 25, 2025, to introduce the RAPID Program, which focuses on utilizing artificial intelligence (AI) and machine learning (ML) for precision diagnostics in rare diseases. The event aims to provide insights into the ARPA-H mission, program goals, and the involvement of Patient Experience (PX) Partners, encouraging participation from patient advocacy groups to enhance the development of innovative diagnostic support tools and comprehensive data integration. This initiative is crucial for addressing the diagnostic challenges faced by rare disease patients, particularly in democratizing access to diagnostics for underserved communities. Registration for the event opens on December 19, 2024, and closes on February 21, 2025; interested parties can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information.

Point(s) of Contact
RAPID Email Box
RAPID@ARPA-H.gov
Files
Title
Posted
RAPID_PXP_Day_Special Notice_FINAL.pdf
Feb 21, 2025, 5:05 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) has announced a virtual Patients’ Day on February 25, 2025, aimed at introducing the RAPID Program, which focuses on employing AI and ML for precision diagnostic solutions in rare diseases. The event will provide insights about the ARPA-H mission, program goals, and the role of Patient Experience (PX) Partners, urging participation from patient advocacy groups. Registration for the event opens on December 19, 2024, and closes on February 21, 2025. The RAPID Program intends to end the diagnostic odyssey faced by rare disease patients by developing innovative diagnostic support tools and fostering comprehensive data integration. It will operate through several technical areas, including creating a massive rare disease dataset, leveraging novel diagnostic indicators, and developing a sustainable platform for AI diagnostic development. RAPID aims to democratize diagnostic access, ensuring benefits for underserved communities while promoting trust and engagement with patients throughout the research and diagnostic development process. This notice emphasizes participation in Patients’ Day as optional, with comprehensive details on PX Partner roles and program structure shared during the event.
Lifecycle
Title
Type
ARPA-H Rare Disease AI/ML and Precision Integrated Diagnostics (RAPID) Patients’ Day
Currently viewing
Special Notice
Similar Opportunities
ARPA-H ImagiNg Data EXchange (INDEX)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program, aimed at developing a sustainable platform to enhance access to medical imaging data. This initiative seeks to address the growing demand for imaging services and the shortage of qualified radiologists by leveraging artificial intelligence and machine learning to streamline data management and analysis. The program is structured in two phases: Phase 0 focuses on business model development, while Phase 1 involves system design and participant enrollment, with an emphasis on ensuring diverse and representative datasets. Interested parties should submit their proposals by April 21, 2025, and can direct inquiries to the INDEX Team at INDEX@arpa-h.gov.
Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
ADAPT Contract Research Organization Support Services
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the ADAPT Contract Research Organization (CRO) Support Services aimed at enhancing precision cancer therapy. The initiative focuses on developing an adaptive cancer treatment platform that integrates advanced analysis techniques and biomarker discovery to improve treatment strategies for metastatic cancer, with key tasks including managing clinical trial data, conducting biological assays, and ensuring regulatory compliance. This procurement is critical for advancing cancer research and improving patient outcomes, with a contract period spanning from July 1, 2025, to June 30, 2030. Interested parties must submit their proposals by April 21, 2025, and can direct inquiries to Steven Snyder at steven.snyder@arpa-h.gov or Clare Sanchez at clare.sanchez@arpa-h.gov.
Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
PROactive Solutions for Prolonging Resilience (PROSPR)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at developing interventions to extend the healthspan of Americans by addressing age-related health decline. This initiative seeks to negotiate multiple Other Transaction Agreements (OTs) with eligible entities, focusing on three key technical areas: the development of an intrinsic capacity score, repurposing FDA-approved interventions, and creating second-generation interventions. The program is significant for transforming geriatric medicine into a preventive care model, emphasizing health equity and proactive health management for aging populations. Interested proposers can find further details and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with key deadlines for proposal submissions set for April and May 2025.
Pharmacogenomics (PGx) Testing for Military Readiness Pilot
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a pilot program focused on pharmacogenomics (PGx) testing to enhance military readiness and healthcare delivery for Active-Duty service members. The initiative aims to establish standardized processes for routine PGx testing within the Military Health System (MHS), leveraging electronic health record (EHR) data to improve clinical decision-making and treatment outcomes. This program is critical for optimizing medication safety and efficacy, ultimately preventing adverse drug reactions and improving overall health conditions for military personnel. Interested parties should contact Dr. Lauren Palestrini at lauren.palestrini@mtec-sc.org, with a funding availability of $2.2 million and a project duration of up to 36 months. The Request for Project Proposals (RPP) is expected to be released soon, with a proposal preparation period of approximately 30 days.
Second Annual DHA INDUSTRY DAY 24 April 2025
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is hosting the Second Annual DHA Industry Day on April 24, 2025, at Fort Detrick, Maryland. This event aims to enhance understanding of the acquisition process among both DoD personnel and vendors, focusing on the statutory and regulatory requirements essential for successful procurement in the defense sector. The Industry Day will feature presentations from DHA and other medical logistics commands, emphasizing the importance of quality products that meet user needs and improve mission capability. Interested participants can register for the event via the provided Eventbrite link, and for further inquiries, they may contact Steve Burrows at judson.s.burrows.civ@health.mil or by phone at 301-619-8538.
Proteomic analyses of dementia and related phenotypes in the Atherosclerosis Risk in Communities (ARIC) Study
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a qualified contractor to perform proteomic analyses of dementia and related phenotypes as part of the Atherosclerosis Risk in Communities (ARIC) Study. The primary objective is to engage a Biostatistician with expertise in analyzing large cohort datasets to assess the impact of immune and vascular risk factors on brain health, particularly concerning Alzheimer's disease. This project is crucial for advancing research on aging and improving health outcomes in older populations. Proposals are due by April 21, 2025, with the anticipated contract period running from May 8, 2025, to May 7, 2026. Interested parties should contact Rashiid Cummins at rashiid.cummins@nih.gov for further details.